Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
Looking for a particular Accelerate Diagnostics employee's phone or email?
Accelerate Diagnostics Questions
The Accelerate Diagnostics annual revenue was $12.2 million in 2026.
Larry Mertz is the Chief Scientific Officer of Accelerate Diagnostics.
48 people are employed at Accelerate Diagnostics.
Accelerate Diagnostics is based in Tucson, Arizona.
The NAICS codes for Accelerate Diagnostics are [32541, 325413, 339, 33, 32, 3254, 325].
The SIC codes for Accelerate Diagnostics are [28, 87, 283, 873].
Top Accelerate Diagnostics Employees
-
11
-
23
-
35+
-
Kurt Reinhardt
Head of Operations at Accelerate Diagnostics
Tucson, AZ, US5 -
Tai Ton
Commercial Development Director at Accelerate Diagnostics
Westminster, MD, US35+ -
15+
-
Nicholas Strohminger
Director of Clinical and Business Analytics at Accelerate Diagnostics
Florida, United States5
Related Companies
